Canntab Partners with Leading Surgeon to Conduct Pain Management Trial
December 14, 2018
Ryan Allway December 14th, 2018 Exclusive, Top News The opioid industry is expected to generate nearly $20 billion in annual revenue by 2020, but the addictive nature of the drug has doctors and patients increasingly concerned. With the legalization of cannabis across Canada and many U.S. states, there’s... Read more
Biome Grow Signs Massive Provincial Supply Agreement
December 6, 2018
Ryan Allway December 6th, 2018 Exclusive, News, Top Story Canada’s cannabis industry has charged forward full-steam following the legalization of recreational cannabis in October. While there was an initial flurry in provincial agreements, many licensed producers experienced a shortfall in their supply commitments. These dynamics encouraged many provinces... Read more
Creso Pharma: A Truly Global Cannabis Company
December 5, 2018
Ryan Allway December 5th, 2018 Exclusive, News, Top News The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many... Read more
Ryan Allway November 28th, 2018 Uncategorized The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for... Read more
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries
November 13, 2018
Ryan Allway November 13th, 2018 Exclusive, News, Top News The cannabis industry is projected to generation hundreds of billions of dollars of revenue over the coming years, driven by the legalization of medical and recreational cannabis across North America. While many investors are focused on cultivation or dispensary... Read more
Ryan Allway November 12th, 2018 News, Top Story Gabriella’s Kitchen (CSE: GABY), the award-winning consumer packaged goods company whose array of super-nutritional foods are currently sold in more than 3,400 stores across North America, is launching a revolutionary new line of cannabis infused nutritional edibles. The expansion as... Read more
CALGARY and SANTA ROSA, CA, Nov. 9, 2018 /CNW/ – Gabriella’s Kitchen Inc. (the “Company” or “GABY”) (CSE: GABY) today provided comments to shareholders on recent changes in United States cannabis regulations, plus other national and international developments in the cannabis sector. GABY commented to shareholders today on recent draft regulations... Read more
CFN Media’s Exclusive Interview with Pascal Biosciences
November 8, 2018
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top Story The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. While many investors are familiar with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
Gabriella’s Kitchen Confirms Its Cannabis-Infused alto™ Products Have Launched in Northern California
November 2, 2018
GABY offers a variety of alto™ products including a line infused with cannabis-derived cannabinoids (including CBD and THC) which are part of GABY’s “better-for-you” edibles line, the first such line to be offered, representing an entirely new approach to cannabis-infused products. The initial alto™ products released consist of infused,... Read more
